Syrian air defenses repel 'Israeli air aggression' - Breaking The News
Download our appPlay StoreApp Store

Syrian air defenses repel 'Israeli air aggression'

EPA-EFE/YOUSSEF BADAWI

Syrian air defenses hastily responded to an "Israeli air aggression," The Times of Israel reported, citing Syria's state-run news agency SANA.

The attack was launched from the direction of Lebanon and targeted a number of locations surrounding Damascus. Some material damage was reported, but no detailed information was given.

This attack came following earlier strikes in the vicinity of Damascus, some of which caused the Damascus Airport to be out of service.

Related News
Pharma stocks drop in Europe amid Trump tariff plans
Stocks of major European pharmaceutical companies, including French Sanofi, British GSK and AstraZeneca, as well as Swiss Roche and Novartis, saw a decline on Wednesday following US President Donald Trump's announcement of a "major tariff" on pharmaceuticals. Trump revealed that Washington would soon impose the tariff, prompting concerns among investors about the potential impact on the global market.At 10:18 am CET, Novartis AG nosedived...
US FDA vaccine director resigns
Director of the United States Center for Biologics Evaluation and Research, Dr. Peter Marks (pictured), the head of the US Food and Drug Administration (FDA) responsible for verifying the safety and efficacy of vaccines, has resigned effective April 5, the Wall Street Journal reported. "It has become clear that truth and transparency are not desired by the [US Health and Human Services (HHS)] Secretary [Robert F. Kennedy Jr.], but rather he wishes subservient...
US Senate confirms Martin Makary to lead FDA
The United States Senate confirmed Dr. Martin Makary, a pancreatic surgeon, as commissioner of the Food and Drug Administration (FDA) in a 56-44 vote. The confirmation means that Makary, a surgeon at Johns Hopkins, will be in charge of regulation and oversight related to drugs, vaccines, food and other products. "Vaccines save lives, and I do believe that any child who dies of a vaccine-preventable illness is a tragedy in the modern era," Makary said...
AstraZeneca pledges $2.5B for R&D center in Beijing
AstraZeneca announced on Friday the investment of $2.5 billion in Beijing to establish its second strategic research and development (R&D) center in China and sixth worldwide. AstraZeneca projects its Beijing staff count will reach 1,700 personnel."This $2.5 billion investment reflects our belief in the world-class life sciences ecosystem in Beijing, the extensive opportunities that exist for collaboration and access to talent, and our continued commitment to China,"...

Please observe our Terms of Use. The price information is time delayed to varying extents, but as a rule by 15 minutes or more, according to the regulations of the selected stock exchange and/or licensors and the type of securities.

© 2025 TeleTrader Software GmbH. All rights reserved

This website uses cookies to ensure you get the best experience. Our Terms of Use and Data Protection Policy explain the data we collect, why we collect them, and how we may share them.